漱玉平民(301017) - 301017漱玉平民投资者关系管理信息20250515

Group 1: Digital Innovation - The company is accelerating its transformation towards "smart pharmaceutical retail" through self-developed digital tools such as PDA, salary calculator, smart store inspection system, and "Yujian" intelligent recommendation system, enhancing service efficiency and customer experience [2] - In the supply chain, the company is optimizing inventory management using algorithm models and digital tools to reduce manual operations and speed up inventory turnover [2] - The company has launched the "Shuyuzhiyuan" risk control platform, utilizing big data models to comprehensively prevent operational risks [2] Group 2: Diversification and Product Development - The company is collaborating with Dashi and Wangwang to establish the "Dashi Shuyuyuan" pharmacy, which will offer a diverse range of products beyond pharmaceuticals, including OTC health products, baby formula, maternal and infant products, nutritional supplements, medical devices, and cross-border products [3] - In 2024, the company's self-owned product sales achieved a year-on-year growth of 9%, accounting for over 13% of total retail sales [3] Group 3: Financial Performance and Store Distribution - The company's asset-liability ratio is slightly higher than the industry average due to its short listing time and small scale of equity financing, with recent market expansion through acquisitions [3] - As of March 2025, the company operates a total of 8,916 stores across Shandong, Liaoning, Heilongjiang, Fujian, Henan, and Gansu provinces, including 4,353 direct-operated stores and 4,563 franchised stores [3]